Doable predictive biomarkers for tumor reaction to mTOR inhibitors, as happen to be explained in glioblastoma, breast and prostate cancer cells, could be the differential expression of mTOR pathway proteins, PTEN, AKT, and S6.[one] Therefore, this details is predicated on preclinical assays, determined by in vitro cultured tumor cell strains, which… Read More